Portfolio - Product list
Browse through our product list.
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 5mg/500mg, 5mg/850mg, 5mg/1000mg, 12.5mg/500mg, 12.5mg/850mg, 12.5mg/1000mg
- REFERENCE PRODUCT: Synjardy ® (Boehringer Ingelheim)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 2mg, 4mg
- REFERENCE PRODUCT: Olumiaant® (Lilly)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Prolonged - release tablets
- STRENGTH: 15mg, 30mg, 45mg
- REFERENCE PRODUCT: Rinvoq® (Abbvie)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Inhalation powder
- STRENGTH: 92mcg/22mcg, 184mcg/22mcg
- REFERENCE PRODUCT: Bro Ellipta® (GSK)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Inhalation powder
- STRENGTH: 55mcg/22 mcg
- REFERENCE PRODUCT: Anoro Ellipta® (GSK)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Inhalation powder
- STRENGTH: 100mcg/74.2mcg/62.5mcg, 200mcg/74.2mcg/62.5mcg
- REFERENCE PRODUCT: Trelegy Ellipta® (GSK)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Film - Coated Tablets
- STRENGTH: 10mg, 20mg
- REFERENCE PRODUCT: Kerendia® (Bayer)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Film - Coated Tablets
- STRENGTH: 180mg
- REFERENCE PRODUCT: Nilemdo® (Esperion, Daiichi Sankyo )
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Film - Coated Tablets
- STRENGTH: 180mg/10mg
- REFERENCE PRODUCT: Nustendi® (Esperion, Daiichi Sankyo )
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Powder for Injection
- STRENGTH: 500mg/2g
- REFERENCE PRODUCT: Zavicefta® (Pfizer)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Solution for injection
- STRENGTH: 12 mg/5ml vial (2.4mg/ml)
- REFERENCE PRODUCT: Spinraza® (Biogen)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Solution for injection
- STRENGTH: 284 mg/1.5 mL prefilled syringe (189 mg/mL)
- REFERENCE PRODUCT: Leqvio® (Novartis)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 12.5mg, 25mg, 50mg, 100mg, 150mg, 200mg
- REFERENCE PRODUCT: Ontozry® (SK Biopharmaceuticals)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Tablets
- STRENGTH: 2.5mg, 5mg, 10mg
- REFERENCE PRODUCT: Delix® (Sanofi)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 40mg, 80mg, 160mg, 320mg
- REFERENCE PRODUCT: Diovan® (Novartis)
- TYPE OF DOSSIER: Under development generics
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg, 320mg/25 mg
- REFERENCE PRODUCT: Codiovan® (Novartis)
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 5mg/850mg, 5mg/1000mg
- REFERENCE PRODUCT: Xigduo® (AstraZeneca)
- Lactose Free: Yes
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 36 months 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 5mg, 10mg
- REFERENCE PRODUCT: Forxiga® (AstraZeneca)
- Lactose Free: Yes
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 36 months 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 10mg, 25mg
- REFERENCE PRODUCT: Jardiance® (Boehringer Ingelheim)
- Lactose Free: Yes
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 36 months 36 months - Not store above 30 oC
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 5mg
- REFERENCE PRODUCT: Trajenta® (Boehringer Ingelheim)
- Lactose Free: Yes
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 36 months 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Hard capsules
- STRENGTH: 120mg
- REFERENCE PRODUCT: Xenical® (Roche)
- Lactose Free: Yes
- Stability: II: available IVb: not available
- Shelf life: 24 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Hard capsules
- STRENGTH: 60mg
- REFERENCE PRODUCT: Alli® (GSK)
- Lactose Free: Yes
- Stability: II: available IVa: not available IVb: not available
- Shelf life: 24 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 25mg, 50mg, 100mg
- REFERENCE PRODUCT: Januvia® (Merck)
- Lactose Free: Yes
- Stability: II: available IVa: not available IVb: available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 50mg/850mg, 50mg/1000mg
- REFERENCE PRODUCT: Janumet® (Merck)
- Lactose Free: Yes
- Stability: II: available IVa: not available IVb: available
- Shelf life: 24 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Tablets
- STRENGTH: 200mg, 400mg, 800mg
- REFERENCE PRODUCT: Zovirax® (GSK)
- Lactose Free: Yes
- Stability: II: available IVa: not available IVb: not available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 10mg, 20mg, 30mg
- REFERENCE PRODUCT: Otezla® (Celgene)
- Lactose Free: Yes
- Stability: II: available IVa: not available IVb: not available
- Shelf life: 18 months (target 36)
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 2.5mg, 5mg
- REFERENCE PRODUCT: Eliquis® (Bristol-Myers Squibb)
- Lactose Free: No
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 2.5mg, 10mg, 15mg, 20mg
- REFERENCE PRODUCT: Xarelto® (Bayer)
- Lactose Free: No
- Stability: II: on-going IVa: ext. from b IVb: on-going
- Shelf life: 24 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Capsules
- STRENGTH: 10mg, 15mg, 20mg
- REFERENCE PRODUCT: Xarelto® (Bayer)
- Lactose Free: No
- Stability: II: available
- Shelf life: 24 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 60mg, 90mg
- REFERENCE PRODUCT: Brilique® (AstraZeneca)
- Lactose Free: Yes
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Hard capsules (IR dosage form)
- STRENGTH: 5mg/2.5mg, 10mg/2.5mg, 5mg/1.25mg, 10mg/1.25mg
- REFERENCE PRODUCT: New combination
- Lactose Free: No
- Stability: II: available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Tablets
- STRENGTH: 12.5mg, 25mg, 50mg
- REFERENCE PRODUCT: Esidrex® (Novartis)
- Lactose Free: No
- Stability: II: available IVa: not available IVb: not available
- Shelf life: 60 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Hard capsules
- STRENGTH: 5mg/5mg, 5mg/10mg, 10mg/5mg, 10mg/10mg
- REFERENCE PRODUCT: Tritace® /Ramipril (Sanofi) & Norvasc®/Amlodipine (Pfizer)
- Lactose Free: Yes
- Stability: II: available IVa: not available IVb: not available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 5mg, 10mg, 20mg
- REFERENCE PRODUCT: Crestor® (AstraZeneca)
- Lactose Free: No
- Stability: II: available IVa: (12 months) IVb: not available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Bilayered Tablets
- STRENGTH: 40mg / 5mg, 40mg / 10mg, 80mg / 5mg, 80mg / 10mg
- REFERENCE PRODUCT: Twynsta® (Boehringer Ingelheim)
- Lactose Free: Yes
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Gel
- STRENGTH: 1mg /g (20g), 1mg /g (30g), 1mg /g (50g)
- REFERENCE PRODUCT: Fenistil(TM) (Novartis)
- Lactose Free: Yes
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 2.5mg, 5mg, 10mg, 20mg
- REFERENCE PRODUCT: Cialis® (Eli Lilly)
- Lactose Free: No
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 48 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 500mg/200mg
- REFERENCE PRODUCT: Nurofen Ultima® (Reckitt Benckiser)
- Stability: II: available IVa: on-going IVb: on-going
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Gastro - resistant hard capsules
- STRENGTH: 120mg, 240mg
- REFERENCE PRODUCT: Tecfidera® (Biogen Idec)
- Lactose Free: Yes
- Stability: II: on-going IVa: ext.from b IVb: on-going
- Shelf life: 36 months / do not store above 30oC (zone II) 24 months / do not store above 30oC (zone IVb)
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 10mg, 20mg
- REFERENCE PRODUCT: Ebixa® (Lundbeck)
- Lactose Free: No
- Stability: II: available IVa: available IVb: no ext. from a
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Film - coated tablets
- STRENGTH: 25mg, 100mg, 150mg, 200mg, 300mg
- REFERENCE PRODUCT: Seroquel® (AstraZeneca)
- Lactose Free: No
- Stability: II: available IVa: available IVb: available
- Shelf life: 36 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Nasal spray solution
- STRENGTH: 1.0mg / 50mg / ml (10ml), 0.5mg / 50mg / ml (10 ml)
- REFERENCE PRODUCT: Nasic(TM) (Cassella-med)
- Lactose Free: Yes
- Stability: II: available IVa: ext. from b IVb: available
- Shelf life: 24 months (0.5mg) 36 months (1.0mg)
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Inhalation powder
- STRENGTH: 44mcg
- REFERENCE PRODUCT: Seebri Breezhaler® (Novartis)
- Lactose Free: No
- Stability: II: available
- Shelf life: 24 monts
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Inhalation powder
- STRENGTH: 43mcg/85mcg
- REFERENCE PRODUCT: Ultibro Breezhaler® (Novartis)
- Lactose Free: No
- Stability: II: available IVb: on-going
- Shelf life: 24 months
- TYPE OF DOSSIER: Available
- PHARMACEUTICAL FORM: Soft capsule
- STRENGTH: 20.000 IU
- REFERENCE PRODUCT: N/A
- Lactose Free: Yes
- Stability: II: available IVa: not available
- Shelf life: 36 months
- TYPE OF DOSSIER: Ophtalmics under development
- INDICATION: Red eye
- DEVELOPMENT PHASE: Lab development
- TYPE OF DOSSIER: Ophtalmics under development
- INDICATION: Dry eye
- DEVELOPMENT PHASE: Lab development
- TYPE OF DOSSIER: Ophtalmics under development
- INDICATION: Dry eye
- DEVELOPMENT PHASE: Lab development
- TYPE OF DOSSIER: Ophtalmics under development
- INDICATION: Infection
- DEVELOPMENT PHASE: Lab development
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 1mg/ml
- Shelf life: 36 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Nemera Novelia ®
- THERAPY DAYS: 30 90
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: No TBD
- PRODUCT ML: 5.0 3 x 5.0
- STORAGE CONDITIONS: Store below 30oC. After first opening use in 90 days.
- BATCH SIZE: 43 860
- POLPHARMA'S BRAND: Olodon® free
- BRAND NAME: Olodon®/ Nolodon®/ Starelltec®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 5mg/ml
- Shelf life: 24 months
- PRESERVATIVE FREE: No
- PRESENTATION: Regular bottle
- THERAPY DAYS: 30
- STABILITY ZONE II: Yes
- STABILITY ZONE IV: No
- PRODUCT ML: 5
- STORAGE CONDITIONS: Once opened - store for 28 days at a temperature below 30oC
- BATCH SIZE: 40 000
- POLPHARMA'S BRAND: Floxamic Neo®
- BRAND NAME: Floxamic®/ Ekara®/ Genaxil®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 0.3mg /ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Nemera Novelia ®
- THERAPY DAYS: 30
- STABILITY ZONE II: Yes
- STABILITY ZONE IV: No
- PRODUCT ML: 3
- STORAGE CONDITIONS: Once opened, do not store above 25oC
- BATCH SIZE: 70 423 25 510
- POLPHARMA'S BRAND: Bimifree®
- BRAND NAME: Bimi®/ Iricryn®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: (0.3mg / 5mg) /ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Nemera Novelia ®
- THERAPY DAYS: 30 90
- STABILITY ZONE II: Yes
- STABILITY ZONE IV: No
- PRODUCT ML: 3
- STORAGE CONDITIONS: Once opened, do not store above 25oC
- BATCH SIZE: 70 423 25 510
- POLPHARMA'S BRAND: Bimifree® Combi
- BRAND NAME: Bimiduo®/ Bapiri®/ Bitifrin®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 2mg /ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Nemera Novelia ®
- THERAPY DAYS: 30 90
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: No No
- PRODUCT ML: 5.0 3 x 5.0
- STORAGE CONDITIONS: Store below 30oC. After first opening use in 90 days.
- BATCH SIZE: 43 103 43 103
- POLPHARMA'S BRAND: Briglau® PPH Free
- BRAND NAME: Briglau®/ Briglafre®/ Rivotra®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 20mg/ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Nemera Novelia ®
- THERAPY DAYS: 30 60
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: No No
- PRODUCT ML: 5.0 10.0
- STORAGE CONDITIONS: Once opened, do not store above 25oC
- BATCH SIZE: 45 455 22 727
- POLPHARMA'S BRAND: Nodofree®
- BRAND NAME: Dimaz®/Itoco®/ Optipres®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: (20mg/5mg) /ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Nemera Novelia ®
- THERAPY DAYS: 30 60
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: No No
- PRODUCT ML: 5.0 10.0
- STORAGE CONDITIONS: Once opened, do not store above 25oC
- BATCH SIZE: 45 455 22 727
- POLPHARMA'S BRAND: Nodofree® Combi
- BRAND NAME: Tidimaz®/ Codimaz®/ Olatalin®/ Olahyd®/ Amiptic®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 0,05mg /ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Aeropump 3K ®
- THERAPY DAYS: 30 90
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: In Use Study
- PRODUCT ML: 2.5 7.5
- STORAGE CONDITIONS: Do not freeze. Do not store above 25ºC Zone IV- 90 days in use study available.
- BATCH SIZE: 54 000 18 000
- POLPHARMA'S BRAND: Xalofree®
- BRAND NAME: Lifog®/Lotacryn®/Loravis®/Lagakomi®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: (0.05mg / 5mg) / ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Aeropump 3K ®
- THERAPY DAYS: 30 90
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: No No
- PRODUCT ML: 2.5 7.5
- STORAGE CONDITIONS: Store and transport 2-8 ºC. Once opened - store for 28 days at a temperature below 25oC
- BATCH SIZE: 54 000 18 000
- POLPHARMA'S BRAND: Xaloptic® Combi
- BRAND NAME: Lifoduo®/Lotaduo®/Loraduo®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 0.04mg / ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Aeropump 3K ®
- THERAPY DAYS: 30 90
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: No No
- PRODUCT ML: 2.5 7.5
- STORAGE CONDITIONS: Do not freeze. After first opening keep the bottle in the outer carton in order to protect from light.
- BATCH SIZE: 55 000 22 000
- POLPHARMA'S BRAND: Tipifree®
- BRAND NAME: Tipifree®/Traslor®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: (0.04mg / 5mg) / ml
- Shelf life: 24 months
- PRESERVATIVE FREE: Yes
- PRESENTATION: Aeropump 3K ®
- THERAPY DAYS: 30 90
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: No No
- PRODUCT ML: 2.5 7.5
- STORAGE CONDITIONS: Store below 25oC. Do not freeze. After first opening keep the bottle in the outer carton in order to protect from light.
- BATCH SIZE: 55 000 22 000
- POLPHARMA'S BRAND: Tipifree® Combi
- BRAND NAME: -
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 250mg
- Shelf life: 60 months
- PRESERVATIVE FREE: No
- PRESENTATION: Tablets
- THERAPY DAYS: 30
- STABILITY ZONE II: No
- STABILITY ZONE IV: No
- STORAGE CONDITIONS: -
- BATCH SIZE: 300 000
- POLPHARMA'S BRAND: Diuramid®
- BRAND NAME: Diuramid®/ Diacarb®
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: 5mg/ml 10mg / ml
- Shelf life: 36 months
- PRESERVATIVE FREE: No No
- PRESENTATION: Regular bottle Regular bottle
- THERAPY DAYS: 30 30
- STABILITY ZONE II: Yes Yes
- STABILITY ZONE IV: No No
- PRODUCT ML: 2 x 5 2 x 5
- STORAGE CONDITIONS: Store below 25oC. After first opening use in 4 weeks.
- BATCH SIZE: 192 000 594 000
- POLPHARMA'S BRAND: Topicamidum WZF®
- BRAND NAME: -
- TYPE OF DOSSIER: Ophtalmics available
- STRENGTH: (3mg +1mg) /ml
- Shelf life: 24 months
- PRESERVATIVE FREE: No
- PRESENTATION: Regular bottle
- THERAPY DAYS: 30
- STABILITY ZONE II: Yes
- STABILITY ZONE IV: No
- PRODUCT ML: 5
- STORAGE CONDITIONS: Store below 25oC. After first opening use in 4 weeks.
- BATCH SIZE: 40 000
- POLPHARMA'S BRAND: Trobosopt-Dex®
- BRAND NAME: -
*Polpharma Group API
CA: Dossier suitable for Canadian market
Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subjected to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the poduct in the import market(s). Based on exemption under art.5(2) of the Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products Apixaban, Ticagrelor, Dapagliflozin and Linagliptin, which are protected by SPCs in Poland, can be manufactured and offered only for the purpose of export to non-EU countries, provided all requirements of the Regulation are met.